Skip to content
Sign inOpen the app
Artwork for On The Pen GLP-1 News
On The Pen GLP-1 News · June 9 · 20 min

Retatrutide Before FDA Approval? Lilly Just Changed the Conversation

Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.

0:00-20:32
Play in podnod

transcript

No transcript — this publisher did not publish one.

show notes

Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.

more episodes

All episodes